NCT01551940 Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea Status COMPLETED Phase PHASE2
NCT01530438 Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis Status UNKNOWN Phase NA
NCT01521728 Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase NA
NCT01511029 Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate) Status COMPLETED Phase PHASE1
NCT01508962 PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01504009 Muscle Training of Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase NA
NCT01495390 A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers Status COMPLETED Phase N/A
NCT01494480 The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Status UNKNOWN Phase PHASE2
NCT01486849 Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT01459302 Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders Status WITHDRAWN Phase N/A
NCT01384162 An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis Status TERMINATED Phase PHASE1/PHASE2
NCT01378676 A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT01378026 Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation Status UNKNOWN Phase N/A
NCT01363401 Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT01348451 Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis Status UNKNOWN Phase PHASE1